Aurora Cannabis Inc. announced the delivery of a cannabis shipment worth approximately CAD 10 million - the company's largest ever shipment to Israel, and what is believed to be the largest export of medical Cannabis into the Israeli market. Delivered in December, the shipment will be recognized as revenue in Aurora's FY22 second quarter period. The sale builds on the Company's growing presence in Israel, a key market as Aurora continues to strengthen its international medical business.

As the leading Canadian licensed producer (LP) in global medical cannabis by revenue, Aurora has strategically focused on international expansion to bolster its diversified business portfolio. The Company also recently entered into a joint venture in The Netherlands to participate in the Controlled Cannabis Supply Chain Experiment, an adult-use pilot program.